DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea
· Delayed Price · Currency is KRW 24,600
-300 (-1.20%)
Apr 29, 2026, 3:30 PM KST
DongKook Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,123,257 | 767,269 | 726,357 | 710,431 | 729,658 | 958,073 | Upgrade
|
| Market Cap Growth | 68.93% | 5.63% | 2.24% | -2.63% | -23.84% | -25.47% | Upgrade
|
| Enterprise Value | 1,172,392 | 823,082 | 792,360 | 751,610 | 743,265 | 932,778 | Upgrade
|
| Last Close Price | 24900.00 | 17150.00 | 16330.33 | 15783.38 | 16031.86 | 20834.20 | Upgrade
|
| PE Ratio | 16.88 | 11.62 | 11.95 | 15.19 | 13.79 | 19.03 | Upgrade
|
| Forward PE | 13.22 | 10.69 | 11.01 | 11.66 | 11.64 | 15.82 | Upgrade
|
| PS Ratio | 1.21 | 0.83 | 0.89 | 0.97 | 1.10 | 1.61 | Upgrade
|
| PB Ratio | 1.47 | 1.00 | 1.07 | 1.18 | 1.31 | 1.90 | Upgrade
|
| P/TBV Ratio | 1.78 | 1.22 | 1.27 | 1.33 | 1.48 | 2.14 | Upgrade
|
| P/FCF Ratio | 43.13 | 29.46 | 14.88 | 93.28 | - | - | Upgrade
|
| P/OCF Ratio | 16.34 | 11.16 | 9.55 | 17.00 | 17.84 | 21.46 | Upgrade
|
| EV/Sales Ratio | 1.26 | 0.89 | 0.98 | 1.03 | 1.12 | 1.57 | Upgrade
|
| EV/EBITDA Ratio | 9.42 | 6.42 | 7.32 | 8.54 | 8.02 | 11.58 | Upgrade
|
| EV/EBIT Ratio | 12.64 | 8.53 | 9.92 | 11.24 | 10.11 | 14.76 | Upgrade
|
| EV/FCF Ratio | 45.01 | 31.60 | 16.24 | 98.69 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.12 | 0.13 | 0.12 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 0.59 | 0.59 | 0.74 | 0.87 | 0.72 | 1.22 | Upgrade
|
| Debt / FCF Ratio | 2.93 | 2.93 | 1.65 | 10.07 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.07 | -0.07 | -0.01 | -0.03 | -0.07 | -0.14 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.40 | -0.40 | -0.09 | -0.20 | -0.44 | -0.89 | Upgrade
|
| Net Debt / FCF Ratio | -1.95 | -1.95 | -0.21 | -2.29 | 5.82 | 11.34 | Upgrade
|
| Asset Turnover | 0.92 | 0.92 | 0.91 | 0.91 | 0.87 | 0.84 | Upgrade
|
| Inventory Turnover | 2.54 | 2.54 | 2.45 | 2.48 | 2.53 | 2.69 | Upgrade
|
| Quick Ratio | 1.39 | 1.39 | 1.26 | 1.34 | 1.49 | 1.40 | Upgrade
|
| Current Ratio | 2.11 | 2.11 | 2.02 | 2.06 | 2.22 | 1.91 | Upgrade
|
| Return on Equity (ROE) | 10.25% | 10.25% | 9.72% | 8.42% | 10.33% | 11.03% | Upgrade
|
| Return on Assets (ROA) | 5.98% | 5.98% | 5.57% | 5.20% | 6.05% | 5.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.90% | 11.15% | 9.36% | 9.75% | 12.39% | 12.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.10% | 12.10% | 11.10% | 10.50% | 12.40% | 11.90% | Upgrade
|
| Earnings Yield | 5.88% | 8.61% | 8.43% | 6.64% | 7.25% | 5.25% | Upgrade
|
| FCF Yield | 2.32% | 3.40% | 6.72% | 1.07% | -0.96% | -0.66% | Upgrade
|
| Dividend Yield | 0.79% | 1.17% | - | - | - | - | Upgrade
|
| Payout Ratio | 14.00% | 14.00% | 13.58% | 17.07% | 15.22% | 15.99% | Upgrade
|
| Buyback Yield / Dilution | -0.05% | -0.05% | -0.01% | -0.02% | -0.01% | - | Upgrade
|
| Total Shareholder Return | 0.74% | 1.12% | -0.01% | -0.02% | -0.01% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.